Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.66 USD | +1.14% | -4.69% | -35.45% |
13/05 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
10/05 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.45% | 349M | |
+50.84% | 63.85B | |
-2.21% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.63% | 26.52B | |
-21.59% | 18.69B | |
+3.10% | 12.73B | |
+22.07% | 12.11B | |
+27.97% | 12.07B |
- Stock Market
- Equities
- ORGO Stock
- News Organogenesis Holdings Inc.
- Organogenesis : Credit Suisse Adjusts Organogenesis Holdings' Price Target to $8 from $7, Keeps Outperform Rating